Skip to main content
Equibles

UBS Group AG

Position in SABS — SAB Biotherapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to SABS Full portfolio

Position in SABS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,426,924
+$1,248,360 QoQ
Shares Held
372,445
+633.0% QoQ
Ownership
0.409%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in SABS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. SABS ranks #241 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in SABS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,426,924 365,878
2026-03-31 $178,564 46,623
2025-12-31 $27,668 7,398
2025-09-30 $26,574 13,221
2025-06-30 $18,704 10,658
2025-03-31 $105 78
2024-12-31 $4,108 1,083
2023-12-31 $344 500
2023-03-31 $2,938 6,679
2022-12-31 $4,086 6,927
2022-09-30 $1,054 1,504
2022-06-30 $1,450 1,000
2022-03-31 $5,290 1,407
2021-12-31 $46,492 5,953